Detalles de la búsqueda
1.
Continuous glucose monitoring-derived time in range and CV are associated with altered tissue characteristics of the carotid artery wall in people with type 2 diabetes.
Diabetologia;
66(12): 2356-2367, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37750893
2.
Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial.
Cardiovasc Diabetol;
22(1): 143, 2023 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37349722
3.
Improvement of beta-cell function in conjunction with glycemic control after medical nutrition therapy in newly-diagnosed type 2 diabetes mellitus.
BMC Endocr Disord;
22(1): 150, 2022 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35658859
4.
Associations of continuous glucose monitoring-assessed glucose variability with intima-media thickness and ultrasonic tissue characteristics of the carotid arteries: a cross-sectional analysis in patients with type 2 diabetes.
Cardiovasc Diabetol;
20(1): 95, 2021 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33947398
5.
Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial.
Cardiovasc Diabetol;
20(1): 4, 2021 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33397376
6.
Long-term (52-week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT-2 study.
Diabetes Obes Metab;
23(7): 1496-1504, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33620762
7.
Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study.
Cardiovasc Diabetol;
19(1): 110, 2020 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32646498
8.
Different daily glycemic profiles after switching from once-daily alogliptin plus twice-daily metformin to their once-daily fixed-dose combination in Japanese type 2 diabetic patients.
Endocr J;
66(1): 11-17, 2019 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30305482
9.
Effects of linagliptin monotherapy compared with voglibose on postprandial lipid profiles in Japanese patients with type 2 diabetes: linagliptin study of effects on postprandial blood glucose (L-STEP) sub-study 1.
Endocr J;
65(4): 415-425, 2018 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29367471
10.
Comparative Effects of an Angiotensin II Receptor Blocker (ARB)/Diuretic vs. ARB/Calcium-Channel Blocker Combination on Uncontrolled Nocturnal Hypertension Evaluated by Information and Communication Technology-Based Nocturnal Home Blood Pressure Monitoringã- The NOCTURNE Study.
Circ J;
81(7): 948-957, 2017 Jun 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-28321001
11.
Marked recovery from glucotoxicity of ß-cell function after medical nutrition therapy without pharmacotherapy in type 2 diabetic outpatients with extreme hyperglycemia: a pilot retrospective study.
Endocr J;
64(11): 1125-1129, 2017 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-28845026
12.
Ameliorated pancreatic ß cell dysfunction in type 2 diabetic patients treated with a sodium-glucose cotransporter 2 inhibitor ipragliflozin.
Endocr J;
62(1): 77-86, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25328035
13.
Efficacy of adding once- and thrice-daily voglibose in Japanese type 2 diabetic patients treated with alogliptin.
Endocr J;
61(5): 447-56, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24561488
14.
Daily Glucose Profiles after Switching from Injectable to Oral Semaglutide in Patients with Type 2 Diabetes Mellitus.
Intern Med;
63(1): 43-50, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37225492
15.
Association between History of Vaccination and Symptoms at Diagnosis of Coronavirus Disease 2019.
JMA J;
6(4): 455-462, 2023 Oct 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37941713
16.
Nighttime home blood pressure lowering effect of esaxerenone in patients with uncontrolled nocturnal hypertension: the EARLY-NH study.
Hypertens Res;
46(7): 1782-1794, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37173430
17.
Long-term efficacy and safety of early alogliptin initiation in subjects with type 2 diabetes: an extension of the SPEAD-A study.
Sci Rep;
13(1): 14649, 2023 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37669959
18.
DAPagliflozin for the attenuation of albuminuria in Patients with hEaRt failure and type 2 diabetes (DAPPER study): a multicentre, randomised, open-label, parallel-group, standard treatment-controlled trial.
EClinicalMedicine;
66: 102334, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38192595
19.
Efficacy of sitagliptin on blood glucose fluctuation in Japanese type 2 diabetic patients with basal-supported oral therapy.
Endocr J;
59(12): 1131-6, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22850206
20.
Lifestyle changes and their impact on glycemic control and weight control in patients with diabetes during the coronavirus disease 2019 pandemic in Japan.
J Diabetes Investig;
13(2): 375-385, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33768726